Treatment of HER2-positive breast cancer: looking backwards briefly.
University of Pittsburgh Cancer Institute, Magee-Women's Hospital, Pittsburgh, PA, 15213, USA.
Shannon
S
Puhalla
Adam
A
Brufsky
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008408:Mastectomy; D020360:Neoadjuvant Therapy / Q000379:methods*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*
D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human